During the past decade, Cancer and Blood Institute of the Desert conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer and Blood Institute of the Desert" #1 sponsor was "Pharmatech Oncology" with 2 trials, followed by "Sanofi" with 2 trials sponsored, "AVAX Technologies" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer and Blood Institute of the Desert" #1 collaborator was "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Mena, Raul, M.D." with 1 trials as a collaborator and "Pharmatech Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cancer and Blood Institute of the Desert" are "Colorectal Cancer" (3 trials), "Lymphoma" (3 trials), "Leukemia" (2 trials), "Lung Cancer" (2 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Cancer and Blood Institute of the Desert" in a lesser frequency.

Most popular intervention types in "Cancer and Blood Institute of the Desert" are "Drug" (11 trials), "Biological" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "oxaliplatin" (3 trials), "cyclophosphamide" (2 trials), "fluorouracil" (2 trials), "leucovorin calcium" (2 trials) and "rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cancer and Blood Institute of the Desert" are 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer and Blood Institute of the Desert". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Cancer and Blood Institute of the Desert, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer and Blood Institute of the Desert, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".